Related Experiment Video
Updated: Aug 11, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Combination therapy for chronic hepatitis C: interferon and ribavirin
1Department of Gastroenterology, John Radcliffe Hospital, Oxford.
Hospital Medicine (London, England : 1998)
|July 9, 1999
Summary
Combination therapy with interferon and ribavirin can clear Hepatitis C virus (HCV) infection in about 40% of patients. This antiviral treatment represents a significant advancement for managing chronic HCV and preventing liver disease.
Area of Science:
- Hepatology
- Virology
- Internal Medicine
Background:
- Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide.
- Chronic HCV infection poses a significant global health burden, necessitating effective treatment strategies.
Purpose of the Study:
- To review the efficacy of combination therapy for chronic Hepatitis C virus infection.
- To highlight the advancements in treating HCV with interferon and ribavirin.
Main Methods:
- Review of recent clinical trials investigating combination therapy for chronic HCV.
- Analysis of treatment outcomes, specifically viral clearance rates.
Main Results:
- Combination treatment with interferon and ribavirin achieves sustained HCV clearance in approximately 40% of patients.
- This therapeutic approach marks a significant improvement over previous treatment options.
Conclusions:
- Interferon and ribavirin combination therapy is an important advance in managing chronic Hepatitis C virus infection.
- The current treatment offers a viable option for a substantial proportion of patients, reducing the risk of severe liver disease.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...